Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA), Initial Review, 19995 [2011-8507]

Download as PDF Federal Register / Vol. 76, No. 69 / Monday, April 11, 2011 / Notices office, with the exception of areas directly involving the conduct of adjudicatory hearings and the rendering of fair and impartial decisions ensuing from those hearings. 03/31/2011 20110618 G General Electric Company; John Wood Group PLC; General Electric Company FOR FURTHER INFORMATION CONTACT: Sandra M. Peay, Contact Representative, or Renee Chapman, Contact Representative, Federal Trade Commission, Premerger Notification Office, Bureau Of Competition, Room H–303, Washington, DC 20580, (202) 326–3100. By Direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2011–8331 Filed 4–8–11; 8:45 am] BILLING CODE 6750–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary srobinson on DSKHWCL6B1PROD with NOTICES Statement of Organization, Functions, and Delegations of Authority Part A, Office of the Secretary, Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services, Chapter AK, Office of Medicare Hearings and Appeals (OMHA), as last amended at 70 FR 36386–36387, dated June 23, 2005, is amended as follows: I. Under Section AK.10 Organization, delete in its entirety and replace with the following: Section AK.10 Organization. The Office of Medicare Hearings and Appeals (OMHA) is under the direction of the Chief Administrative Law Judge (CALJ), who reports directly to the Secretary. OMHA consists of the following components: • Medicare Hearings and Appeals Chief Judge’s Office (CJO) (Headquarters Office) (AKA) —Office of Operations (AKA1) —Office of Programs (AKA2) • Medicare Hearings and Appeals Field Offices (AKB1–AKB4) II. Under Section AK.20 Functions, Paragraph A, ‘‘The Office of Medicare Hearings and Appeals Immediate Office (AK),’’ delete the second paragraph, which begins with, ‘‘The Executive Director (ED) of OMHA/IO, reports to the CALJ, and is responsible for all operational matters * * *’’ in its entirety and replace with the following: Within OMHA/CJO, the Director, Office of Operations and the Director, Office of Programs, both of whom report to the CALJ, are responsible for all operational matters and for executive and managerial oversight, respectively, in support of the mission of the VerDate Mar<15>2010 17:49 Apr 08, 2011 Jkt 223001 III. Under Section AK.20 Functions, Paragraph B, ‘‘Medicare Hearings and Appeals Field Offices (AKB1–4),’’ delete the first paragraph, which begins with, ‘‘The Field Offices are headed by a Managing Administrative Law Judge (MALJ) who reports directly to the CALJ. The Managing Administrative Law Judge (MALJ) acts on behalf of the CALJ at the respective field office location on all matters involving the hearing process, and is directly responsible for the effective execution of the hearings process within the field location * * *,’’ in its entirety and replace with the following: OMHA’s Field Offices are headed by the Associate Chief Administrative Law Judges, all of whom report directly to OMHA’s Chief Administrative Law Judge (CALJ). Each Field Office’s Associate Chief Administrative Law Judge (ACALJ) acts on behalf of the OMHA CALJ at his or her respective field office location on all matters involving the hearing process and is directly responsible for the effective execution of the hearings process within the field location. Each Field Office’s ACALJ is responsible for: (a) Providing direction, leadership, management and guidance to the field office staff, including Supervisory Administrative Law Judges (SALJs) and their staffs, (b) field office implementation of policies, goals, objectives, and procedures pertaining to the hearings process and formulating policies, goals, and objectives for the SALJs and support staff in their field office; (c) planning, organizing and administering field operations for scheduling and conducting independent and impartial hearings on appealed determinations involving adjudicatory hearings for authorities delegated to the SALJs by the Secretary; (d) developing and recommending OMHA action with respect to allegation of unfair hearings within the field operations; (e) upon request by SALJs, providing advice and guidance in matters related to adjudicating cases under the provisions of the Social Security Act; and (f) conducting adjudicatory hearings under authorities delegated to the SALJs by the Secretary. IV. Under Section AK.20 Functions, Paragraph B, ‘‘Medicare Hearings and Appeals Field Offices (AKB1–4),’’ replace all reference to the ‘‘Hearing Office Manager’’ as the ‘‘Hearing Office Director’’ and all references to the ‘‘HOM’’ as the ‘‘HOD.’’ V. Delegation of Authority. Pending further delegation, directives or orders by the Secretary or by the Chief Administrative Law Judge, all delegations and re delegations of authority made to officials and employees of affected organizational components will continue in them or PO 00000 Frm 00045 Fmt 4703 Sfmt 9990 19995 their successors pending further re delegations, provided they are consistent with this reorganization. Dated: January 25, 2011. E.J. Holland, Jr., Assistant Secretary for Administration. [FR Doc. 2011–8356 Filed 4–8–11; 8:45 am] BILLING CODE 4150–24–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement (FOA), Initial Review The meeting announced below concerns ‘‘National Spina Bifida Registry Longitudinal Data Collection and Evaluation,’’ FOA DD11–005, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1 p.m.–5 p.m., May 17, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘National Spina Bifida Registry Longitudinal Data Collection and Evaluation,’’ FOA DD11–005, initial review. Contact Person for More Information: Brenda Colley Gilbert, Ph.D., M.P.H., Director, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 1600 Clifton Road, NE., Mailstop K92, Atlanta, Georgia 30333, Telephone: (770) 488–6295. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: April 4, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–8507 Filed 4–8–11; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\11APN1.SGM 11APN1

Agencies

[Federal Register Volume 76, Number 69 (Monday, April 11, 2011)]
[Notices]
[Page 19995]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8507]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Funding Opportunity Announcement (FOA), Initial 
Review

    The meeting announced below concerns ``National Spina Bifida 
Registry Longitudinal Data Collection and Evaluation,'' FOA DD11-005, 
initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

Time and Date:
1 p.m.-5 p.m., May 17, 2011 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``National Spina Bifida Registry Longitudinal Data 
Collection and Evaluation,'' FOA DD11-005, initial review.
    Contact Person for More Information: Brenda Colley Gilbert, 
Ph.D., M.P.H., Director, Extramural Research Program Office, 
National Center for Chronic Disease Prevention and Health Promotion, 
CDC, 1600 Clifton Road, NE., Mailstop K92, Atlanta, Georgia 30333, 
Telephone: (770) 488-6295.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: April 4, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-8507 Filed 4-8-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.